Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-09-24FDA Approved: GEMCITABINE HYDROCHLORIDE — Supplemental Application (Teyro Labs Private Limited)
FDA approved a supplemental application for Gemcitabine hydrochloride from Teyro Labs Private Limited, authorizing continued approval of thi…
-
CLINICAL_TRIALS research · 2024-09-23Clinical Trial Update: Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating Tg01 Vaccine with QS-21 Stimulon, with or without balstilimab, as maintenance therapy after adjuvant chemo…
-
CLINICAL_TRIALS research · 2024-09-20Clinical Trial Update: SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients [Phase 1]
A Phase 1 trial evaluating stereotactic body radiotherapy (SBRT) with a PD-1 inhibitor for late-stage or recurrent pancreatic cancer has bee…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Progression-free Survival After MWA Plus Durvalumab and Tremelimumab for Unresectable Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating progression-free survival in patients with unresectable, locally advanced pancreatic cancer treated with m…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses [NA]
A clinical trial comparing EUS-guided Fine Needle Biopsy (FNB) versus Fine Needle Aspiration (FNA) with on-site cytopathology for solid panc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Prevalence and Consequences of Hyperlactemia Following Pancreatic Surgery
A completed clinical trial report examining how common hyperlactatemia is after pancreatic surgery and the associated consequences.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Evaluation of Survival Prognostic Factors for Patients With Exocrine Pancreatic Cancer Resectable or Potentially Resectable [NA]
A completed clinical trial update evaluating survival prognostic factors in patients with resectable or potentially resectable exocrine panc…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
A prospective study conducted by Fudan University evaluating the use of liquid biopsy for early detection of pancreatic cancer; recruitment …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms [NA]
A completed clinical trial evaluating multidimensional prehabilitation in pancreatic surgery for pancreatic and periampullary neoplasms.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors [Phase 1, Phase 2]
A Phase 1b/2a trial evaluating ENB003 in combination with pembrolizumab for various solid tumors, including melanoma, ovarian cancer, pancre…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED) [NA]
Terminated clinical trial (NODMED) evaluating whether managing new-onset diabetes can enable earlier detection of pancreatic cancer; no resu…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: A Study to See Whether a Nutritional Supplement is Beneficial for Patients With Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating a nutritional supplement for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]
A Phase 1/2 trial of CEND-1 Injection (QLC12102) in advanced metastatic pancreatic ductal adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 study evaluating S-1 as second-line therapy for metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer [Phase 3]
A Phase 3 trial evaluating perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer [Phase 1]
This clinical trial update reports the Phase 1 study of CEND-1 in combination with nab-paclitaxel and gemcitabine for metastatic pancreatic …
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: QUILT-3.080: NANT Pancreatic Cancer Vaccine [Phase 1, Phase 2]
Clinical trial update for QUILT-3.080 (NANT Pancreatic Cancer Vaccine) in pancreatic cancer; the Phase 1/2 study by ImmunityBio has been ter…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer [Phase 3]
Phase 3 trial comparing liposomal irinotecan with oxaliplatin and S-1 versus gemcitabine with capecitabine as postoperative adjuvant therapy…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Oral Protein Supplements for Nutritional and Quality of Life Improvement After Pancreatic Resection in Elderly Patients [NA]
A completed clinical trial from Yonsei University evaluated whether oral protein supplements improve nutrition and quality of life after pan…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study of CBP-1019, a bi-ligand-drug conjugate, in patients with advanced solid tumors incl…
-
CLINICAL_TRIALS research · 2024-08-23Clinical Trial Update: CTS2190 Phase I /II Clinical Study in Patients [Phase 1, Phase 2]
CTS2190 is a Phase 1/2 clinical study by CytosinLab Therapeutics evaluating CTS2190 in solid tumors, including pancreatic cancer, non-small …
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Lidocaine Infusion With ERAS Protocol for Pancreatic Cancer Surgery: Effect on Pain and Patient Immunity. [NA]
A completed clinical trial evaluating lidocaine infusion within an ERAS protocol for pancreatic cancer surgery and its effects on postoperat…
-
CLINICAL_TRIALS label_change · 2024-08-21Clinical Trial Update: Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer [EARLY_Phase 1]
This is an early-phase 1 clinical trial update for pancreatic cancer evaluating nivolumab plus all-trans retinoic acid. The trial is current…
-
CLINICAL_TRIALS withdrawal · 2024-08-21Clinical Trial Update: Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study [NA]
A clinical trial evaluating mesothelin-targeted CAR-T cells as neoadjuvant therapy for resectable pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-08-20Clinical Trial Update: Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer [NA]
A completed clinical trial evaluating the effects of red ginseng on postoperative gastrointestinal symptoms and gut microbiota in cancer pat…